Medidata
Medidata is a cloud-based life sciences platform provider that unifies clinical research processes across pharmaceutical, biotech, medical device, and diagnostics companies, as well as academic and government researchers. The company offers the Medidata Clinical Cloud for data capture, management, analytics, trial planning and management; Medidata Detect for centralized statistical monitoring; and patient-centric tools such as myMedidata to support flexible trial participation. Its platform integrates data management, analytics, and patient engagement to accelerate development and commercialization of therapies, with professional services including implementation, sponsor enablement, strategy consulting, partner support, and training. Medidata serves customers worldwide through direct sales and partner networks and collaborates with industry and research organizations to expand trial insights. Founded in 1999 and based in New York, Medidata focuses on accelerating value, reducing risk, and improving outcomes in life sciences.
Top Stages
https://app.dealroom.co/companies/***
https://crunchbase.com/organization/***
https://linkedin.com/company/***
12 past transactions
Circuit Clinical
Venture Round in 2022
Circuit Clinical is an integrated research organization that has emerged from the experience of a physician engaged in clinical research within a private practice. Established in 2015, the company aims to enhance the way clinical research is conducted by emphasizing physician and participant engagement. Circuit Clinical leverages a network of over 1 million patients, utilizing direct HIPAA/FDA-compliant Electronic Medical Record reviews to identify motivated participants. The organization provides research services that facilitate access to clinical research, guiding both experienced and novice community physicians and their patients through each step of the clinical research process. Through its technology products and focus on participant and physician experience, Circuit Clinical seeks to improve research site quality and patient safety, creating a more efficient pathway for clinical research.
AllStripes
Series B in 2021
AllStripes is a healthcare technology company focused on accelerating the development of new treatments for rare diseases. The company has created a platform that enables the generation of regulatory-ready evidence, facilitating rare disease research and drug development. AllStripes operates a two-sided network that connects patients with rare diseases and advocacy groups to life science companies seeking new drug candidates. Through this network, patients can contribute their medical data and participate in treatment research online, while life science companies gain access to valuable data and insights to support their drug development efforts.
SHYFT Analytics
Acquisition in 2018
SHYFT Analytics provides cloud-based data management, analytics, and mobile solutions for the life sciences industry. Its platform integrates clinical and commercial data to produce patient-centric intelligence and analytics for use across research, development, commercialization, and market access, helping shorten cycle times and improve decision making. The repertoire includes modules for Sales, Specialty, Launch, Rare Disease, and Market Access, along with Real World Evidence capabilities that translate RWE data into actionable insights. The company also offers services in launch and commercial analytics, clinical analytics and operations, insight-driven design, and market access strategies. It serves pharmaceutical and biotechnology companies and collaborates with industry partners such as PAREXEL International. SHYFT Analytics is based in Waltham, Massachusetts, and operates as a subsidiary of Medidata Solutions.
Syapse
Series D in 2017
Syapse, Inc. is a technology company that specializes in precision medicine through its innovative software platform, which aggregates and analyzes clinical, molecular, treatment, and outcomes data. Founded in 2008 and headquartered in San Francisco, California, with an additional office in Radnor, Pennsylvania, Syapse aims to enhance healthcare by providing actionable insights that support data-driven decision-making in precision oncology. The company operates the Syapse Learning Health Network, a global network that enables health systems and life sciences collaborators to share real-world cancer data. This network empowers healthcare organizations to collaborate effectively, ensuring that oncologists and decision-makers have access to comprehensive patient insights at the point of care, ultimately driving improved outcomes for cancer patients. Syapse has established strategic partnerships, including a collaboration with Pfizer, to further its mission of delivering personalized care based on robust real-world evidence.
Mytrus
Acquisition in 2017
Mytrus, Inc. is an e-clinical technology company based in Davis, California, specializing in patient-centered electronic informed consent and data collection tools for clinical trials. Founded in 2009, Mytrus develops innovative solutions that allow patients to participate in clinical studies remotely, enhancing accessibility and compliance while reducing costs. Its offerings include electronic patient-reported outcomes (ePRO), electronic data capture (EDC) tools, bio-sample consent tracking technology, and patient home dashboards that facilitate the tracking of clinical study progress and data. Mytrus also possesses a patent for conducting virtual clinical trials in the United States. As of 2017, it operates as a subsidiary of Medidata Solutions, Inc.
SHYFT Analytics
Series B in 2017
SHYFT Analytics provides cloud-based data management, analytics, and mobile solutions for the life sciences industry. Its platform integrates clinical and commercial data to produce patient-centric intelligence and analytics for use across research, development, commercialization, and market access, helping shorten cycle times and improve decision making. The repertoire includes modules for Sales, Specialty, Launch, Rare Disease, and Market Access, along with Real World Evidence capabilities that translate RWE data into actionable insights. The company also offers services in launch and commercial analytics, clinical analytics and operations, insight-driven design, and market access strategies. It serves pharmaceutical and biotechnology companies and collaborates with industry partners such as PAREXEL International. SHYFT Analytics is based in Waltham, Massachusetts, and operates as a subsidiary of Medidata Solutions.
Chita
Acquisition in 2017
Chita, Inc. is a company based in San Mateo, California, specializing in enterprise content management solutions tailored for the life sciences sector. The company provides a unified platform that enables users to create, store, view, collaborate on, and edit both regulated and non-regulated content within a single application. Its offerings include a role-based system, flexible document workflows, file access control, and features such as electronic signatures and audit trails. These capabilities allow life sciences organizations to manage their content needs more effectively, fostering collaboration and ensuring compliance in a modern digital workplace. Chita operates as a subsidiary of Medidata Solutions, Inc.
SHYFT Analytics
Series B in 2016
SHYFT Analytics provides cloud-based data management, analytics, and mobile solutions for the life sciences industry. Its platform integrates clinical and commercial data to produce patient-centric intelligence and analytics for use across research, development, commercialization, and market access, helping shorten cycle times and improve decision making. The repertoire includes modules for Sales, Specialty, Launch, Rare Disease, and Market Access, along with Real World Evidence capabilities that translate RWE data into actionable insights. The company also offers services in launch and commercial analytics, clinical analytics and operations, insight-driven design, and market access strategies. It serves pharmaceutical and biotechnology companies and collaborates with industry partners such as PAREXEL International. SHYFT Analytics is based in Waltham, Massachusetts, and operates as a subsidiary of Medidata Solutions.
Intelemage
Acquisition in 2016
Intelemage, LLC is a company based in Cincinnati, Ohio, specializing in PACS administration, network management, software development, and software application security solutions tailored for the radiology and telecommunications industries. The firm operates The InteleGRID image sharing network, a robust platform that facilitates the acquisition, management, and distribution of medical images for a diverse clientele, including pharmaceutical and medical device companies, hospitals, healthcare facilities, and professional sports leagues. Intelemage plays a critical role in enhancing collaboration among medical device and pharmaceutical companies, core labs, contract research organizations, hospitals, and physicians by providing advanced clinical data workflow management and electronic data capture solutions. As a trusted partner of many renowned institutions, Intelemage ensures efficient and secure medical image and clinical data exchanges. Since April 2016, Intelemage has functioned as a subsidiary of Medidata Solutions, Inc.
Clinical Force
Acquisition in 2011
Clinical Force is a privately-held company that specializes in providing a comprehensive Clinical Trials Management System (CTMS) tailored for the life sciences sector. With a significant presence in both the United States and Europe, the company has developed software solutions aimed at improving clinical processes for small to medium-sized life science organizations. Clinical Force leverages its extensive experience with contract research organizations and sponsors, enabling it to create better communication and collaboration between these stakeholders. The company's applications are designed to be economical and user-friendly, facilitating the adoption of improved practices in clinical trial management across four continents.
Fast Track
Acquisition in 2008
Fast Track: a completely new and comprehensive approach to the way clinical trials are managed. The company is assembling a creative and energetic staff of technical and medical professionals, an experienced management team, industry-specific advisory boards, and an active investor constituency - all aggressively focused on achieving their vision: to revolutionize the management of clinical trials.
Medidata
Venture Round in 2002
Medidata is a cloud-based life sciences platform provider that unifies clinical research processes across pharmaceutical, biotech, medical device, and diagnostics companies, as well as academic and government researchers. The company offers the Medidata Clinical Cloud for data capture, management, analytics, trial planning and management; Medidata Detect for centralized statistical monitoring; and patient-centric tools such as myMedidata to support flexible trial participation. Its platform integrates data management, analytics, and patient engagement to accelerate development and commercialization of therapies, with professional services including implementation, sponsor enablement, strategy consulting, partner support, and training. Medidata serves customers worldwide through direct sales and partner networks and collaborates with industry and research organizations to expand trial insights. Founded in 1999 and based in New York, Medidata focuses on accelerating value, reducing risk, and improving outcomes in life sciences.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.